Cargando…

Fibronectin urothelial gene expression as a new reliable biomarker for early detection of local toxicity secondary to adjuvant intravesical therapy for non-muscle invasive bladder cancer

BACKGROUND: A marker of urothelial damage could be helpful for early detection and monitoring of local toxicity due to intravesical therapy for non-muscle invasive bladder cancer (NMIBC). The aim of the study was to investigate the correlation between fibronectin (FN) gene expression in bladder wash...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Maida, Fabrizio, Scalici Gesolfo, Cristina, Tellini, Riccardo, Mari, Andrea, Sanfilippo, Chiara, Lambertini, Luca, Grosso, Antonio Andrea, Carini, Marco, Minervini, Andrea, Serretta, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923969/ https://www.ncbi.nlm.nih.gov/pubmed/33717214 http://dx.doi.org/10.1177/1756287221995683

Ejemplares similares

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
por: Serretta, Vincenzo, et al.
Publicado: (2015)

Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer
por: Mari, Andrea, et al.
Publicado: (2020)

Assessing the impact of socio‐economic determinants on access to care, surgical treatment options and outcomes among patients with renal mass: Insight from the universal healthcare system
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Robot-assisted partial nephrectomy with 3D preoperative surgical planning: video presentation of the florentine experience
por: Grosso, Antonio Andrea, et al.
Publicado: (2021)

Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
por: Serretta, Vincenzo, et al.
Publicado: (2018)

An uncommon case of sarcomatoid urothelial carcinoma in covered bladder exstrophy
por: Pavone, Carlo, et al.
Publicado: (2016)

Patterns and Predictors of Optimal Surgical and Functional Outcomes after Holmium Laser Enucleation of the Prostate (HoLEP): Introducing the Concept of “Trifecta”
por: Grosso, Antonio Andrea, et al.
Publicado: (2023)

Three-dimensional reconstruction and intraoperative ultrasonography: Crucial tools to safely approach highly complex renal masses
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

How far is too far? Exploring the indications for robotic partial nephrectomy in a highly complex kidney tumor
por: Minervini, Andrea, et al.
Publicado: (2020)

The Natural History of Peyronie's Disease
por: Di Maida, Fabrizio, et al.
Publicado: (2021)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burden
por: Maida, Fabrizio Di, et al.
Publicado: (2023)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Robotic reconstruction of vesico-urethral anastomosis stenosis: a descriptive technique and short-term results
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Robotic Partial Nephrectomy with En Bloc Removal of a Renal Vein Thrombus for Multiple cT3a Renal Cell Carcinoma Lesions
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Re: Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial
por: Minervini, Andrea, et al.
Publicado: (2019)

Exploring the Diversity and Predictors of Histopathological Findings Across the European Association of Urology Guidelines Office Rapid Reaction Group Priority Groups for Patients with Renal Tumors: Implications for Individualized Prioritization of Renal Cancer Care
por: Campi, Riccardo, et al.
Publicado: (2021)

Robot-assisted sacro(hystero)colpopexy with anterior and posterior mesh placement: impact on lower bowel tract function and clinical outcomes at mid-term follow-up
por: Li Marzi, Vincenzo, et al.
Publicado: (2022)

The impact of COVID-19 on the male genital tract: A qualitative literature review of sexual transmission and fertility implications
por: Verrienti, Pierangelo, et al.
Publicado: (2022)

Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature
por: Mari, Andrea, et al.
Publicado: (2017)

How To Deal with Renal Cell Carcinoma Tumors >7 cm: The Role of Nephron-sparing Surgery
por: Minervini, Andrea, et al.
Publicado: (2021)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Referee
por: Minervini, Andrea, et al.
Publicado: (2022)

Characterization of human infiltrating and circulating gamma-delta T cells in prostate cancer
por: Vella, Marco, et al.
Publicado: (2019)

Holmium laser ablation of the prostate (HoLAP) with moses technology for the surgical treatment of benign prostatic hyperplasia
por: Grosso, Antonio Andrea, et al.
Publicado: (2021)

Editorial: Influences in the progression of renal cell carcinoma
por: Bacchiani, Mara, et al.
Publicado: (2022)

Predictors of early catheter replacement after HoLEP. Results from a high-volume laser center
por: Maida, Fabrizio Di, et al.
Publicado: (2023)

Deferring Elective Urologic Surgery During the COVID-19 Pandemic: The Patients’ Perspective
por: Campi, Riccardo, et al.
Publicado: (2021)

Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
por: Li, Gang, et al.
Publicado: (2017)

High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
por: Mekayten, Matan, et al.
Publicado: (2018)

Templates of Lymph Node Dissection for Renal Cell Carcinoma: A Systematic Review of the Literature
por: Campi, Riccardo, et al.
Publicado: (2018)

Bacillus Calmette–Guerin intravesical instillation therapy-induced urothelial necrosis of the bladder and upper urinary tract
por: Kondo, Tsubasa, et al.
Publicado: (2022)

Redo Partial Nephrectomy for Local Recurrence After Previous Nephron-sparing Surgery. Surgical Insights and Oncologic Results from a High-volume Robotic Center
por: Di Maida, Fabrizio, et al.
Publicado: (2023)

Letter to the Editor: “Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection”
por: Di Maida, Fabrizio, et al.
Publicado: (2020)

Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
por: D’Andrea, David, et al.
Publicado: (2019)

Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
por: Liu, J., et al.
Publicado: (2023)

Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer
por: Magalhães, Joana C, et al.
Publicado: (2023)

The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder
por: Lu, Chi-Chen, et al.
Publicado: (2013)

Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008)

High-grade hyperinvasive sarcomatoid urothelial bladder carcinoma demonstrating complete response to bladder-preserving chemoradiation
por: Wallach, J.B., et al.
Publicado: (2009)

Intravesical drug delivery approaches for improved therapy of urinary bladder diseases
por: Palugan, Luca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bmkonmtukamkahsnu7rrktve88